(Q34512706)

2 August 2017

1 reference

title

Systematic review of antibiotic resistance in acne: an increasing topical and oral threat (English)

1 reference

2 August 2017

main subject

antibiotic resistance

1 reference

1 reference

3

Brigitte Dréno

0 references

author name string

Timothy R Walsh

series ordinal

1

1 reference

2 August 2017

John Efthimiou

series ordinal

2

1 reference

2 August 2017

publication date

4 February 2016

1 reference

Lancet Infectious Diseases

2 August 2017

published in

1 reference

2 August 2017

volume

16

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

e23-33

1 reference

Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Prevalence, morbidity, and cost of dermatological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

New understandings of the pathogenesis of acne

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Prevalence of facial acne vulgaris in late adolescence and in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Pathogenesis and Pathogenesis Related Treatment of Acne

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Comedogenesis: some new aetiological, clinical and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

The relationship between seborrhoea and acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Propionibacterium Levels In Patients With And Without Acne Vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Inflammation in acne vulgaris.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

The evolving role of Propionibacterium acnes in acne

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Effects of Subantimicrobial-Dose Doxycycline in the Treatment of Moderate Acne

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Management of acne: a report from a Global Alliance to Improve Outcomes in Acne.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Antibiotic stewardship in dermatology: limiting antibiotic use in acne

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Bacterial resistance in French acne patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Antibiotic-resistant acne: lessons from Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

European evidence-based (S3) guidelines for the treatment of acne.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Propionibacterium acnes resistance: a worldwide problem

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Propionibacterium acnes: an update on its role in the pathogenesis of acne

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Induction of toll-like receptors by Propionibacterium acnes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Role of macrolide therapy in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: investigating practice gaps and potential cost-savings.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Challenges of antibacterial discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

A new antibiotic and the evolution of resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

UK and European Union public and charitable funding from 2008 to 2013 for bacteriology and antibiotic research in the UK: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

UK declares war on antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Antimicrobial espionage?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Antibiotic resistance--problems, progress, and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Antibiotics: achieving the balance between access and excess.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Laboratory Induction and Clinical Occurrences of Combined Clindamycin and Erythromycin Resistance in Corynebacterium acnes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Recalcitrant acne vulgaris. Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

First report of high levels of clindamycin-resistant Propionibacterium acnes carrying erm(X) in Japanese patients with acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Antibiotic resistance of microbial strains isolated from Korean acne patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Antibiotic resistance in acne: is it time to look beyond antibiotics and Propionobacterium acnes?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Effect of Antibiotics on the Oropharyngeal Flora in Patients With Acne

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Antibiotic treatment of acne may be associated with upper respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Chronic destructive oligoarthritis associated with Propionibacterium acnes in a female patient with acne vulgaris: septic-reactive arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Propionibacterium acnes, an emerging pathogen: from acne to implant-infections, from phylotype to resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Analysis of complete genomes of Propionibacterium acnes reveals a novel plasmid and increased pseudogenes in an acne associated strain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Detection of a new erm(X)-mediated antibiotic resistance in Egyptian cutaneous propionibacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Treatment of acne with topical antibiotics: lessons from clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Bacterial skin commensals and their role as host guardians

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Penetration into bone and tissues of clindamycin phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Recent lessons for the management of bone and joint infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Antibiotic overuse and resistance in dermatology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Association of pharyngitis with oral antibiotic use for the treatment of acne: a cross-sectional and prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Propionibacterium acnes: an underestimated pathogen in implant-associated infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Mediastinitis after cardiac surgery: improvement of bacteriological diagnosis by use of multiple tissue samples and strain typing

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Propionibacterium acnes endocarditis on an annuloplasty ring in an adolescent boy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

In vitro emergence of rifampicin resistance in Propionibacterium acnes and molecular characterization of mutations in the rpoB gene

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Topical antibiotics: therapeutic value or ecologic mischief?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

1 reference

7 January 2021

Status report on antibiotic resistance: implications for the dermatologist

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Meta-analysis of randomized controlled trials using 5% benzoyl peroxide and clindamycin versus 2.5% benzoyl peroxide and clindamycin topical treatments in acne

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Propionibacterium acnes strain populations in the human skin microbiome associated with acne

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Dense genomic sampling identifies highways of pneumococcal recombination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

The quality of life in acne: a comparison with general medical conditions using generic questionnaires.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

The prevalence and risk factors of adolescent acne among schoolchildren in Lithuania: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900527-7

7 January 2021

10.1016/S1473-3099(15)00527-7

Identifiers

DOI

1 reference

2 August 2017

1 reference